Susan D. Wyrick
Keine laufenden Positionen mehr
Karriereverlauf von Susan D. Wyrick
Ehemalige bekannte Positionen von Susan D. Wyrick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01.02.2013 | 11.06.2014 |
Ausbildung von Susan D. Wyrick
| University of Washington | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Susan D. Wyrick
- Erfahrung
